274 related articles for article (PubMed ID: 8960614)
21. Placental ratio and risk of velamentous umbilical cord insertion are increased in women with placenta previa.
Papinniemi M; Keski-Nisula L; Heinonen S
Am J Perinatol; 2007 Jun; 24(6):353-7. PubMed ID: 17564954
[TBL] [Abstract][Full Text] [Related]
22. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
23. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
24. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?
Villar J; Carroli G; Wojdyla D; Abalos E; Giordano D; Ba'aqeel H; Farnot U; Bergsjø P; Bakketeig L; Lumbiganon P; Campodónico L; Al-Mazrou Y; Lindheimer M; Kramer M;
Am J Obstet Gynecol; 2006 Apr; 194(4):921-31. PubMed ID: 16580277
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction.
Odibo AO; Sehdev HM; Stamilio DM; Macones GA
Am J Perinatol; 2006 Aug; 23(6):363-7. PubMed ID: 16841275
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
[TBL] [Abstract][Full Text] [Related]
27. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
28. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
[TBL] [Abstract][Full Text] [Related]
29. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
30. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
31. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
32. The relationship between perinatal outcome of singleton pregnancies and isolated highly elevated levels of maternal serum human chorionic gonadotropin at mid-gestation.
Tavor O; Shohat M; Lipitz S
Isr Med Assoc J; 2007 Jul; 9(7):509-12. PubMed ID: 17710780
[TBL] [Abstract][Full Text] [Related]
33. Middle cerebral/umbilical artery resistance index ratio as sensitive parameter for fetal well-being and neonatal outcome in patients with preeclampsia: case-control study.
Ebrashy A; Azmy O; Ibrahim M; Waly M; Edris A
Croat Med J; 2005 Oct; 46(5):821-5. PubMed ID: 16158478
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
35. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
Chen Y; Dai X; Wu B; Jiang C; Yin Y
BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
[TBL] [Abstract][Full Text] [Related]
36. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
37. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler.
Hershkovitz R; de Swiet M; Kingdom J
Hypertens Pregnancy; 2005; 24(3):273-80. PubMed ID: 16263599
[TBL] [Abstract][Full Text] [Related]
38. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
[TBL] [Abstract][Full Text] [Related]
39. Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes.
Brajenović-Milić B; Tislarić D; Zuvić-Butorac M; Bacić J; Petrović O; Ristić S; Mimica M; Kapović M
Fetal Diagn Ther; 2004; 19(6):483-7. PubMed ID: 15539871
[TBL] [Abstract][Full Text] [Related]
40. Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay.
Spaggiari E; Ruas M; Dreux S; Valat AS; Czerkiewicz I; Guimiot F; Schmitz T; Delezoide AL; Muller F
Am J Obstet Gynecol; 2013 Apr; 208(4):303.e1-7. PubMed ID: 23313312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]